The size of the Asia Pacific Mammography Market is predicted to reach USD 488.37 million by 2027 from its current value of USD 343.36 million in 2022, growing at a significant CAGR of 7.3% between 2022 to 2027.
While breast cancer prevails as one of the deadliest diseases among women, the need for early diagnosis of breast cancer has increased rising the demand for mammography. With the increasing mortality rate of breast cancer patients, the demand for these devices is likely to sustain in the foreseeable future.
Mammography is a standard diagnostic and screening devices used in examining the breast tissues with the help of images for the presence of any malignant tissues. The detailed imaging of the inside of the breast is made possible with the low dose x-ray system for the early-stage detection of cancer. While screening mammography involves random checking among women without any signs of breast cancer, diagnostic mammography involves checking of cancer if there are any specific symptoms related to breast cancer. It is also used to evaluate the results of a screening mammogram.
Rising cancer population, the evolvement of new breast imaging technologies, the rising aging population, increasing awareness regarding cancer symptoms are driving the growth of the mammography market. However, the market is hindered by the considerable cost incurred, stringent regulatory laws and side effects that are associated with the mammography.
This research report on the Asia Pacific Mammography Market has been segmented and sub-segmented the Asia Pacific Mammography Market into the following categories:
In Japan, the prevalence of breast cancer is significantly increasing over the past few years. Around 14000 women are dying due to breast cancer every year in Japan, which is creating more demand for the mammography systems in this country and is favouring the market growth. Japan also adopted a soft-copy reading of digital mammography for very complex processes. Mammography Subcommittee of the Japan Radiological Society arranges the campaign to spread information about mammography and breast cancer.
In Australia, Breast cancer is the second largest cause of women deaths and is the most lucrative region for the mammography market to grow in the near future. The Australian mammography market is estimated to display a robust CAGR during the forecast period.
Disorganised population-based mammography programs for breast cancer in India, limited availability of mammography units, trained radiologists are majorly driving the 1qmammography market in India. Many of the senior breast radiologists of India are working in Pan Indian mammography Society, which is estimated to propel the Indian mammography market growth.
Some of the promising companies leading the Asia Pacific Mammography Market profiled in the report include Fujifilm, GE Healthcare, Hologic, Metaltronica, Philips Healthcare, Planmed, Siemens Healthcare, Sonocine, and Toshiba Medical Systems.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com